Global estimate of the incidence of clinical pneumonia among children under five years of age by Rudan, Igor et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Global estimate of the incidence of clinical pneumonia among
children under five years of age
Citation for published version:
Rudan, I, Tomaskovic, L, Boschi-Pinto, C, Campbell, H & WHO Child Health Epidemiology Reference
Group 2004, 'Global estimate of the incidence of clinical pneumonia among children under five years of age'
Bulletin of the World Health Organization, vol. 82, no. 12, pp. 895-903.
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Bulletin of the World Health Organization
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
895Bulletin of the World Health Organization | December 2004, 82 (12)
Introduction
Acute respiratory infections (ARI) in children less than ﬁve 
years old are the leading cause of childhood mortality in the 
world. Most of these deaths are caused by pneumonia and 
bronchiolitis. WHO estimated that the annual number of 
ARI-related deaths in this age group (excluding those caused by 
measles and pertussis and neonatal deaths) was 2.1 million (1), 
accounting for about 20% of all childhood deaths. This was 
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Objective Clinical pneumonia (deﬁned as respiratory infections associated with clinical signs of pneumonia, principally pneumonia 
and bronchiolitis) in children under ﬁve years of age is still the leading cause of childhood mortality in the world. In this paper we 
aim to estimate the worldwide incidence of clinical pneumonia in young children.
Methods Our estimate for the developing world is based on an analysis of published data on the incidence of clinical pneumonia 
from community-based longitudinal studies. Among more than 2000 studies published since 1961, we identiﬁed 46 studies that 
reported the incidence of clinical pneumonia, and 28 of these met pre-deﬁned quality criteria.
Findings The estimate of the median incidence from those studies was 0.28 episodes per child-year (e/cy). The 25–75% interquartile 
range was 0.21–0.71. We assessed the plausibility of this estimate using estimates of global mortality from acute respiratory infections 
and reported case-fatality rates for all episodes of clinical pneumonia reported in community-based studies or the case-fatality rate 
reported only for severe cases and estimates of the proportion of severe cases occurring in a deﬁned population or community.
Conclusion The overlap between the ranges of the estimates implies that a plausible incidence estimate of clinical pneumonia 
for developing countries is 0.29 e/cy. This equates to an annual incidence of 150.7 million new cases, 11–20 million (7–13%) of 
which are severe enough to require hospital admission. In the developed world no comparable data are available. However, large 
population-based studies report that the incidence of community-acquired pneumonia among children less than ﬁve years old is 
approximately 0.026 e/cy, suggesting that more than 95% of all episodes of clinical pneumonia in young children worldwide occur 
in developing countries.
Keywords Pneumonia/epidemiology/mortality; Bronchiolitis/epidemiology/mortality; Child, Preschool; Incidence; Longitudinal studies; 
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Voir page 901 le résumé en français. En la página 901 ﬁgura un resumen en español.
based largely on estimates of mortality published by Williams 
et al. (2). The primary aim of this paper is to estimate the 
incidence of pneumonia and bronchiolitis in the developing 
world. This can be considered a close approximation of the 
global incidence of these conditions because nearly 90% of 
children less than ﬁve years old live in developing countries 
(2), and the incidence of these diseases is substantially greater 
among children in developing countries (3, 4). This work was 
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commissioned and directed by the Child Health Epidemiol-
ogy Reference Group (CHERG) which is coordinated by the 
Department of Child and Adolescent Health (CAH) of WHO, 
and the estimates obtained were subject to critical review by 
this group.
Acute lower respiratory infections (ALRI) are deﬁned in 
the International statistical classiﬁcation of diseases and related 
health problems, tenth revision, as those infections that affect 
the airways below the epiglottis. These include acute manifes-
tations of laryngitis, tracheitis, bronchitis, bronchiolitis, lung 
infections, any combination of these, or any of these along with 
upper respiratory infections, including inﬂuenza. The focus of 
the global burden of disease programme has been on condi-
tions accounting for a substantial loss of disability-adjusted life 
years. Within CHERG, a decision was made to concentrate on 
pneumonia and bronchiolitis because these are considered to 
be the major components of ALRI that account for the global 
burden of disease from acute respiratory infections among 
young children. This approach is consistent with the WHO 
approach to the case management of ARI, which was intro-
duced ﬁrst by the programme for the control of ARI in order 
to standardize and facilitate clinical decision-making in places 
with limited resources and which has now been incorporated 
into the global Integrated Management of Childhood Illness, 
or IMCI, programmes. IMCI programmes train health workers 
to identify fast breathing, lower chest wall indrawing or selected 
danger signs in children with respiratory symptoms (such as 
cyanosis or an inability to drink). For the programme’s purposes, 
these are labelled “pneumonia”, although it is recognized that 
children identiﬁed in this way include those with pneumonia, 
bronchiolitis and a proportion of those with reactive airways 
disease associated with a respiratory infection. The studies re-
viewed in this paper have adopted this approach and we have 
called the conditions identiﬁed “clinical pneumonia”. The 
review thus reports episodes of pneumonia, bronchiolitis and, 
in some studies, reactive airways disease associated with respira-
tory infections; it does not report episodes of acute laryngitis, 
bronchitis or tracheitis.
Methods
Our estimate is based on an analysis of published data on the 
incidence of clinical pneumonia from community-based lon-
gitudinal studies that met pre-deﬁned quality criteria (5–32). 
We assessed the plausibility of our estimate (and the internal 
consistency of incidence, mortality and case-fatality data) in two 
ways. The ﬁrst approach was based on the reported total number 
of childhood deaths due to ARI (1) and our best approxima-
tion of the case-fatality rate from all cases of clinical pneumonia 
in a community (21, 22, 33, 34). The second approach was 
based on the reported total number of childhood deaths due 
to ARI (1), reported case-fatality rates only for severe episodes of 
clinical pneumonia (those that require hospital admission) (26, 
35–45), and estimates of the proportion of severe cases in a 
deﬁned population or community (1, 5, 8, 20, 23, 46, 47).
Box 1 details the research plan. The initial literature review 
was performed by searching Medline, Science Citation Index 
and Current Contents for data from the period 1961–2000. 
Search terms included acute (lower) respiratory infections, 
bronchiolitis, croup, pneumonia, tracheobronchitis, children, 
under ﬁve years, developing countries, incidence, mortality, epi-
demiology, and combinations of these terms. Free text searches 
were performed in the title and abstract ﬁelds in PubMed and 
Ovid. The WHO library database (WHOLIS) was searched for 
journals, documents, publications and reports not indexed on 
Medline. Additional electronic databases searched included the 
WHO Statistical Information System (WHOSIS), UNICEF, 
the UN Population Division, and the US Centers for Disease 
Control and Prevention’s National Center for Health Statistics 
database; this last resource also pointed us towards signiﬁcant 
reports from unpublished “grey” literature including national 
reports and unpublished studies (A Marx, unpublished data, 
2000).
After reviewing more than 2000 studies, we selected the 
most informative studies. These studies estimated the incidence 
of clinical pneumonia among children less than ﬁve years old in 
a developing country or provided information that helped us to 
understand the determinants of clinical pneumonia occurrence, 
aetiology, clinical features, management, case-fatality rate or 
outcome in developing countries. A pre-deﬁned set of key data 
was extracted systematically from each study and recorded in 
an electronic database. (This information is available from 
http://www.who.int/child-adolescent-health/New_Publica-
tions/Overview/ari_db.htm.)
The review then focused on studies that met the minimum 
quality criteria (Box 1). The minimum criteria were that:
• community-based surveillance of a deﬁned population of 
children had to have been carried out for a minimum period 
of one year (and in multiples of 12 months) because clinical 
pneumonia has such a markedly seasonal nature;
• the study had to use a strategy of active case detection. The 
surveillance interval had to be 2 weeks or shorter to mini-
mize recall bias;
• case deﬁnitions had to be clearly deﬁned and consistently 
applied.
Applying these criteria yielded 28 studies that formed the basis 
of this review. Their geographical distribution and reported 
incidence rates are shown in Fig. 1, and their characteristics are 
summarized in Table 1, web version only, available at: http://
www.who.int/bulletin.
An attempt was made to ensure that the reported inci-
dence rates across a full age range of 0–4 years were comparable 
between the studies. When different incidence rates were pro-
vided for several cohorts within the same study (e.g., separately 
by village or sex), a weighted mean was calculated. In cases where 
intervention studies were undertaken, only the incidence rate in 
the control (“no intervention”) arm of the trial was used in the 
analysis. When studies reported incidence only for restricted 
age ranges of children (e.g., 0.5–3 years), an adjustment to the 
full age range was performed. This was based on the mean age-
speciﬁc incidence ratios obtained from ﬁve studies that reported 
incidence separately for each of the 1-year age groups (5, 14, 
26, 27, 32). Relative to an incidence of 1.0 in the ﬁrst year of 
life, the mean ratios across the ﬁve studies for the other four 
years were 0.58 (year 2), 0.48 (year 3), 0.31 (year 4) and 0.19 
(year 5). These ratios were used to adjust reported incidences 
to the full 0–4 year age range when necessary.
Controlling for differences in study design
We needed to ensure that all of the longitudinal studies were 
measuring the same entity using comparable study designs or to 
introduce appropriate corrections if this was not the case. Our 
main concern was that differences in case deﬁnitions might 
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Box 1. Steps in the research plan
Step Aim No. of studies
1 Review all studies published from 1961 to 2001 that referred to acute respiratory infections, developing 2200 
 countries and children 
2 Select studies that either:  308 
 •  directly attempt to estimate incidence of clinical pneumonia in children younger than ﬁve years of age in  
  developing countries, or  
 •  provide information that helps to understand the determinants of the occurrence of clinical pneumonia,  
  its etiology, clinical features, management, case-fatality rates, and outcomes in developing countries 
3 Create electronic knowledge database that classiﬁes information presented in the 308 studies into 30 different  308 
 categories. This database is available from http://www.who.int/child-adolescent-health/New_Publications/Overview 
4 Select studies that satisfy the criteria of:  46 
 • community-based longitudinal studies 
 • estimate the incidence of clinical pneumonia
5 Further selection from these 46 studies of those that satisfy ﬁve pre-deﬁned criteria:  28 
 • community-based surveillance of a pre-deﬁned population of children 
 • study lasting a minimum of one year 
 • active case detection 
 • surveillance intervals of 2 weeks or shorter  
 • case deﬁnitions clearly deﬁned and consistently applied 
6 Identify studies from these 28 that: 4 
 • were community-based longitudinal studies, and  
 • reported the case-fatality rate for all episodes in a community 
7 Identify studies from these 28 that: 6 
 • were community-based longitudinal studies and 
 • reported the proportion of severe episodes of clinical pneumonia in all episodes of clinical pneumonia  
8 Identify studies from these 28 that: 12 
 • were community-based or hospital-based studies, and  
 • reported the case-fatality rate for severe episodes of clinical pneumonia
9 Calculate the global estimate of the incidence of clinical pneumonia in children aged 0–4 years as: Not applicable 
 • median of incidence reported by 28 studies in Step 5 
 • overall mortality divided by the median case-fatality rate for all clinical pneumonia from studies in Step 6 
 • overall mortality divided by median case-fatality rate for severe clinical pneumonia from studies in Step 8  
  and by median proportion of severe episodes of clinical pneumonia in all episodes from studies in Step 7
This yields three independent global estimates of incidence of acute lower respiratory infections in children aged 0–4 years.
produce estimates that were not comparable. A simple classi-
ﬁcation of ARI into three categories according to severity was 
proposed by WHO in 1985 to deﬁne a classiﬁcation system 
that would be useful in community-based studies in developing 
countries (48). The WHO ARI classiﬁcation system deﬁnes 
episodes of ARI as:
(1) severe if there is cough and chest indrawing, cough and 
not being able to drink, or stridor at rest (requiring hospital 
referral);
(2) moderate if there is cough and fast breathing but no chest 
indrawing (requiring home treatment with antimicrobials and 
supportive measures); or
(3) mild if there is cough without fast breathing ( 50 breaths 
per minute) and no chest indrawing, with sore throat, ear 
discharge for more than 2 weeks and blocked or runny nose 
(requiring home treatment with supportive measures only).
In each of the 28 studies, we were primarily interested in deter-
mining whether clinical pneumonia was diagnosed by a non- 
physician (i.e., a trained ﬁeld worker or lay reporter) or a physi-
cian or paediatrician. In these studies, trained ﬁeld workers or 
lay reporters based their diagnosis of clinical pneumonia on 
whether a child had a respiratory rate at or above the threshold 
of 50, or lower chest wall indrawing (which is included in the 
moderate or severe category of the WHO ARI classiﬁcation), 
or both (49, 50). The physicians based their diagnosis on ex-
perience and supported it with chest auscultation to identify 
signs consistent with pneumonia or bronchiolitis.
Case deﬁnition
We aimed to investigate whether non-physicians were likely 
to overdiagnose cases regardless of how strict the criteria were 
that they used. Therefore, using their deﬁnition of a case, we 
divided all 28 studies into either category I (diagnosis estab-
lished by non-physicians) or category II (diagnosis established 
by physicians). Our hypothesis was that studies in category II 
would generally report lower estimates of incidence. Table 1 
(web version only, available at: http://www.who.int/bulletin) 
shows whether diagnosis was done by a physician or non-phy-
sician for the majority of cases of clinical pneumonia in the 
community by study.
To further explore the possible effects of differences in 
case deﬁnition on incidence, we studied the diagnostic criteria 
used within the group of studies in which non-physicians had 
the principal role in diagnosis (that is, category I studies). 
Among those we identiﬁed studies in which the diagnostic 
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criteria were based on WHO deﬁnition only (called category 
I-A) or also included 1–3 additional criteria, such as cyanosis or 
shock (called category I-B), or four or more such criteria (cat-
egory I-C). We presumed that the more additional criteria there 
were, the lower the estimates should be. Also, in some studies 
within category I, case deﬁnitions also allowed for wheeze 
(classiﬁed as W+), which could bias the estimates upwards, or 
required crepitations to be heard on auscultation (designated 
as C+/R+), which might lower the estimates. Appendix 1 (web 
version only, available at: http://www.who.int/bulletin) gives 
further details on how we developed four case deﬁnition variables 
to explore the possible effects of these differences.
Understanding determinants of variation in 
incidence of clinical pneumonia
We treated all 28 studies as random data points from their 
speciﬁc setting within the developing world, each of which was 
needed to produce a global estimate. Thus, their results needed 
adjustment only for differences in study design and not for dif-
ferences in settings. However, an additional attempt was made 
to improve our understanding of the determinants of variations 
in incidence by investigating the effects of 15 variables related 
to the design or setting of each study. Most of these variables 
were quantitative (altitude, annual rainfall, average annual tem-
perature, median year of study, mean cohort size, duration of 
study and duration of surveillance intervals). These are shown in 
detail in Table 1 (web version only, available at: http://www.who.
int/bulletin). Qualitative variables (information on population, 
who diagnosed clinical pneumonia, place of diagnosis, risk of 
malaria and ALRI case deﬁnition) were speciﬁcally categorized 
(Table 2 (web version only, available at: http://www.who.int/ 
bulletin)).
To investigate the effect of case deﬁnition on the es-
timated incidence, four different case deﬁnition variables 
(CDV1–CDV4) were developed (Appendix 1, (web version 
only, available at: http://www.who.int/bulletin)). A number 
of other factors known to be related to the incidence of clini-
cal pneumonia (such as prevalence of malnutrition, low birth 
weight, whether the child had been breastfed, incomplete vac-
cination status, or overcrowding at home) were not reported 
consistently enough to be included in the regression model 
(although their national prevalence was used in a subsequent 
study to produce estimates for WHO regions). The correlation 
between the 15 variables and the estimates of the incidence of 
clinical pneumonia was ﬁrst investigated through univariate 
regression analysis. Because the number of studies included 
was relatively small, only the six variables that had the most 
signiﬁcant correlation with incidence were entered into the 
multiple regression analysis. The other variables were omit-
ted to ensure that the number of studies is approximately ﬁve 
times greater than the number of selected variables, to improve 
the statistical power of this analysis. Statistical analysis was 
done using Systat 7.0 for Windows software and the Poisson 
regression model.
Estimation of incidence and ranges
Because the incidence reported in the individual studies reﬂect 
only their speciﬁc settings, their results should not necessarily 
be viewed as representative of the country or region where 
the study took place. However, each study represents a valid 
incidence estimate from the surveillance of a number of popu-
lations in developing countries that are widely scattered across 
the world (Fig. 1). Our estimate of the incidence in develop-
ing countries is thus based on the median incidence from 28 
community-based studies. The burden of clinical pneumonia 
among the minority of children less than ﬁve years old who 
live in developed countries (about 13% of children less than 
ﬁve years old worldwide (1)) was inferred from the population 
estimate for the year 2000 by the United Nations Population 
Division and population-based studies of the incidence of 
clinical pneumonia in the United States of America and the 
United Kingdom (3, 4).
We assessed the plausibility (and internal consistency with 
other related data) of the estimate for the developing world 
using two approaches. In the ﬁrst approach, global ARI mor-
tality was divided by the median, 25th and 75th percentile 
values of case-fatality rates for all clinical pneumonia reported 
in the literature. In the second approach, global ARI mortality 
was divided by the median, 25th and 75th percentile values of 
reported case-fatality rates only for severe cases of pneumonia, 
and also by the median, 25th and 75th percentile values of the 
proportions of all clinical pneumonia cases reported as severe 
(requiring admission to hospital).
Results
Table 1 (web version only, available at: http://www.who.int/
bulletin) summarizes the data on study design and incidence 
from the 28 studies that satisﬁed the inclusion criteria (5–32). 
They are listed in chronological order and classiﬁed according 
to WHO region. Most of the studies were performed in the 
following regions: the South-East Asia Region (11 studies; eight 
in subregion D and three in subregion B), the Western Paciﬁc 
Region (six studies; all in subregion B), the African Region (four 
studies; all in subregion D), and the Region of the Americas 
(four studies; all in subregion B). Only two studies were avail-
able from subregion D of the Region of the Americas and 
only one study from subregion E of the African Region; none 
were available from the Eastern Mediterranean Region. (See 
http://www.who.int/about/contactregional/en/ for details of 
WHO regions.)
The majority of studies (19; 68%) were performed in the 
late 1980s. Fourteen studies were performed in rural popula-
tions, seven in suburban areas, six in urban areas, and one study 
covered several different populations. Seven studies were carried 
out near sea level, while seven others investigated populations 
living at an altitude higher than 1500 m. The average annual 
rainfall at the study sites ranged from almost none in Peru 
to 2500 mm in Costa Rica. The mean annual temperatures 
ranged from 15 ºC in China to 29 ºC in Thailand. The period 
of follow-up was 1 year in 12 studies, 2 years in nine studies, 
and 3 years in seven studies. The size of the cohort was fewer 
than 300 children in six studies, 300–1000 in 12 studies, and 
more than 1000 in 10 studies. The surveillance intervals were 
weekly or more frequently in 18 studies (64%). In eight stud-
ies physicians or paediatricians established the diagnosis; in 
11 diagnosis was performed solely by lay reporters or trained 
ﬁeld workers; and in nine studies trained ﬁeld workers were 
principally involved in establishing the diagnosis, but subsets 
of children under surveillance were checked or ﬁeld workers 
were assisted by physicians. In 20 studies (71%) the incidence 
was reported across the full age range (0–4 years), while in eight 
it was adjusted as described earlier.
Two studies (from the Gambia and Peru) reported on 
both clinical pneumonia as deﬁned by clinical criteria and ra-
diologically conﬁrmed pneumonia. These studies reported that 
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Fig. 1. Map showing the location of the 28 studies and the distribution of reported incidence of clinical pneumonia. (Numbers on the
map refer to study numbers shown in Table 1 (web version only, available at: http://www.who.int/bulletin))
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the percentage of radiologically conﬁrmed pneumonia was 
only 24–36% of the estimates of the incidence as measured 
by community surveillance.
Reports of the percentage of episodes considered severe 
from four studies ranged from 6–12%. The generalizability of 
these four studies is not known. (The mean incidence from 
these studies is higher than from all 28 studies.) The estimated 
incidence was less than 0.1 episode per child-year (e/cy) in 
four studies, 0.1–0.5 e/cy in 14 studies, 0.6–1.0 e/cy in four 
studies, and more than 1.0 e/cy in six studies. The variation 
in estimates of incidence seemed large and had a bimodal 
distribution (Fig. 1). However, this is perhaps not surprising 
given the wide variety of risk factors underlying the incidence 
of clinical pneumonia in developing countries. We considered 
these risk factors further in our subsequent study on incidence 
in different WHO regions. For the purpose of this study it was 
important to ensure that elements of study design (the case 
deﬁnition of clinical pneumonia in particular) were not respon-
sible for systematic deviations in incidence. To account for this, 
a multiple regression analysis was performed to determine the 
effects of 15 study characteristics on incidence.
The multiple regression analysis of variables that could 
inﬂuence reported incidence was limited to those variables 
that were provided in the majority of published reports. The 
main purpose was to determine whether any further adjust-
ment needed to be made to the incidence because the four case 
deﬁnitions signiﬁcantly affected the estimates. In the initial 
univariate analysis, only the most basic difference in case deﬁ-
nition (WHO criteria compared with physician’s assessment) 
showed any correlation with reported incidence, but it was a 
rather weak correlation. In studies that allowed episodes of 
wheezing to be scored as clinical pneumonia or which extended 
the deﬁnition to also include ﬁndings on chest auscultation 
or additional rarer features of clinical pneumonia (such as 
cyanosis and heart failure), we were unable to demonstrate 
any signiﬁcantly increased estimates of incidence under any 
model (Table 2, web version only, available at: http://www.
who.int/bulletin).
In order to increase the statistical power of the analysis, 
given the small number of data points and the large number 
of variables, the six most signiﬁcant predictors from the initial 
analysis were entered into the multiple regression analysis. This 
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showed that only annual rainfall and the place where the child 
was diagnosed were statistically signiﬁcantly correlated with 
incidence. Since both of these factors reﬂect the setting of the 
study rather than the design of the study, we concluded that 
there was no need for further adjustment.
The effect of annual rainfall on overall incidence has not 
been reported previously. We investigated whether this effect 
might be due to the misclassiﬁcation of malaria episodes (pre-
senting as fast breathing) by categorizing studies by level of 
intensity of transmission of falciparum malaria. There was no 
evidence to support the idea of misclassiﬁcation. Some of the 
alternative hypotheses to be explored further are the relation-
ship of the amount of time children spend crowded together 
indoors, higher risks of transmission of respiratory infections in 
rainy climates and the greater bacterial superinfection of viral 
ARI episodes in humid conditions.
Table 3 presents the annual estimates of clinical pneu-
monia for the year 2000 for developing countries (where the 
total population of children aged 0–4 years is estimated to be 
523.3 million) using the approaches described in the Methods 
section. The median estimate of incidence was 0.28 episodes 
per child-year. The 25–75% interquartile range of the estimate 
was 0.21-0.71 e/cy.
To check the plausibility of the main estimate we used 
two approaches. The ﬁrst approach was based on global ARI 
mortality and reported case-fatality rates for all clinical pneu-
monia. This was less robust than the above estimate since we 
Table 3. Global estimates of incidence (range) of clinical pneumonia in children aged 0–4 years. Incidence expressed as 
episodes/child-year (e/cy)
Approach 25th (or 75th)  Median  75th (or 25th) 
 percentilea  percentileb
Developing world (main approach)
Incidence of clinical pneumonia measured directly (28 studies; refs 5–32) 0.205 e/cy 0.280 e/cy 0.710 e/cy
Annual no. of new cases of clinical pneumonia in millions (based on total  107.3 146.5 371.6 
population of children aged 0–4 years in developing world)
Plausibility check (approach 1)
Case-fatality rate for all episodes of clinical pneumonia (4 studies; refs 21, 22, 33, 34) 2.60% 1.95% 1.30%
Related clinical pneumonia incidence (based on 2.1 million deaths annually; ref. 1) 0.152 e/cy 0.203 e/cy 0.305 e/cy
Annual No. of new cases of clinical pneumonia in millions (based on total population  79.5 106.2 159.6 
of children aged 0–4 years in developing world)
Plausibility check (approach 2)
Case-fatality rate for episodes of severe clinical pneumonia (12 studies; refs 26, 35–45) 11.05% 9.90% 7.80%
Proportion of severe episodes of clinical pneumonia in all episodes  12.80% 9.20% 6.70% 
(6 studies; refs 5, 8, 20, 23, 46, 47)
Related clinical pneumonia incidence (based on 2.1 million deaths annually; ref. 1) 0.280 e/cy 0.435 e/cy 0.757 e/cy
Annual no. of new cases of clinical pneumonia in millions (based on total population  146.5 227.6 396.2 
of children aged 0–4 years in developing world)
Developed world
Directly measure incidence of pneumonia (median of four estimates from large  NAc 0.026 e/cy NAc 
population-based studies in the USA and Europe; refs 3, 4, 52, 53)
Annual no. of new cases of clinical pneumonia in millions (based on total population  NAc 2.1 NAc 
of children aged 0–4 years in developed world)
a  As a result of the inverse relationship between some variables in this table, this represents the 75th percentile if the results are presented in decreasing value  
 over the percentile range.
b  As a result of the inverse relationship between some variables in this table, this represents the 25th percentile if the results are presented in decreasing value  
 over the percentile range.
c  NA = not applicable.
could only identify four community-based studies that gave a 
valid estimate of the case-fatality rate. These estimates varied 
quite widely: 0.2%, 1.3%, 2.6% and 3.2% (21, 22, 33, 34). 
This yielded a median incidence of 0.20 e/cy (25–75% inter-
quartile range 0.15–0.31).
The second approach was based on the proportion of 
cases of severe clinical pneumonia acquired in the community 
and the reported case-fatality rate for severe cases. Estimates 
of the case-fatality rate were available from 12 studies (26, 
35–45) and ranged from 6.6–14.1%. Similarly, the proportion 
of severe community-acquired episodes was available from six 
community-based studies (5, 8, 20, 23, 46, 47) and ranged from 
5.9–16.8%. This produced a median incidence of 0.44 e/cy 
with a range of 0.28–0.76 e/cy (based on the 25–75% inter-
quartile ranges of case-fatality rates and of reported proportions 
of severe clinical pneumonia).
The ranges obtained by the main approach and the 
two ancillary approaches overlap between the values of 146 
million and 159 million new episodes of clinical pneumonia 
per year. Giving the most weight to the estimate obtained 
through the main approach, but also taking into account the 
results of the other two approaches, the analyses suggest that 
the most plausible point of overlap is close to 0.29 e/cy. This 
equates to 150.7 million new cases of clinical pneumonia, 
11–20 million (7–13%) of which are severe enough to require 
hospital admission.
We were unable to identify any population-based studies 
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from developed countries that used active surveillance and simi-
lar case deﬁnitions. In Table 3 we show the median estimate of 
incidence in young children reported in four large population-
based studies in the United States and Europe. This median 
estimate of 0.026 e/cy (3, 4, 51, 52) is approximately 10% of 
the estimate of clinical pneumonia in developing countries, but 
these results are not directly comparable because the studies 
used different methods of case ascertainment and different deﬁ-
nitions. However, this estimate represents 2.1 million cases of 
pneumonia occurring in a population of 81.6 million children 
less than ﬁve years old in developed countries (1).
The number of studies from developing countries that 
we judged to meet a limited number of essential quality criteria 
was small. Summarizing the ﬁndings of these studies is compli-
cated by differences in their design and settings. Some of the 
communities being studied could have had particularly high 
mortality from ARI, thus further limiting the generalizability 
of the ﬁndings. None of the studies reported the incidence of 
clinical pneumonia in areas where there is a high prevalence of 
HIV. It is clear, therefore, that despite our efforts to identify 
valid estimates and to control for confounding and modifying 
factors, estimates of ALRI incidence in children in developing 
countries continue to be uncertain. In particular there is a need 
for studies to deﬁne current incidence in settings where HIV is 
a signiﬁcant public health problem. The results of this review 
should therefore be interpreted with caution.
Conclusion
This review highlights the magnitude of the burden of clinical 
pneumonia in developing countries where often only mortal-
ity is considered. This study’s deﬁnition of clinical pneumonia 
encompassed the clinical conditions of pneumonia, bronchi-
olitis and reactive airways disease associated with respiratory 
infections (although the proportion of the episodes due to the 
latter was low in the populations discussed). These episodes 
result in acute suffering and short-term complications and have 
a detrimental effect on a child’s nutritional status and may also 
inﬂuence the risk of other childhood diseases. In addition, a 
number of studies have suggested that clinical pneumonia in 
early childhood may have long-term consequences for respira-
tory function and health. This review demonstrates the sub-
stantial variation in annual incidence among young children 
in different settings. This points to the potential to intervene 
against risk factors to prevent clinical pneumonia and signiﬁ-
cantly reduce the large burden of disease in childhood resulting 
from clinical pneumonia.  O
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Résumé
Estimation de l’incidence mondiale de la pneumopathie clinique chez les enfants de moins de cinq ans
Objectif La pneumopathie clinique (déﬁnie comme l’ensemble 
des infections respiratoires associées à des signes cliniques de 
pneumopathie, principalement la pneumonie et la bronchiolite) 
chez l’enfant de moins de cinq ans reste la cause majeure de 
mortalité infantile dans le monde. Le but de cet article est d’estimer 
l’incidence mondiale de la pneumopathie clinique chez les jeunes 
enfants.
Méthodes L’estimation pour les pays en développement repose 
sur l’analyse des données publiées au sujet de l’incidence de 
la pneumopathie clinique et tirées d’études longitudinales en 
communauté. Les auteurs ont établi que, parmi les plus de 2000 
études publiées depuis 1961, 46 rapportent  l’incidence de la 
pneumopathie clinique et 28 répondent aux critères de qualité 
prédéﬁnis.
Résultats D’après ces études, l’incidence médiane est estimée à 
0,28 épisode par enfant - année (ép./e.a). L’intervalle interquartile 
25-75 % correspond à 0,21-0,71 ép./e.a. Les auteurs ont évalué la 
plausibilité de cette estimation à partir d’estimations de la mortalité 
mondiale par infections respiratoires aiguës et des taux de létalité 
indiqués pour l’ensemble des épisodes de pneumopathie clinique 
rapportés dans les études en communauté ou du taux de létalité 
indiqué uniquement pour les cas graves et des estimations de la 
proportion de cas graves survenant dans une population ou une 
communauté déﬁnie.
Conclusion D’après le recouvrement entre les intervalles de 
ﬁabilité des estimations, on peut conclure que 0,29 ép/e.a constitue 
une estimation plausible de l’incidence de la pneumopathie 
clinique dans les pays en développement. Ce chiffre équivaut à 
une incidence annuelle de 150,7 millions de nouveaux cas, dont 
11 à 20 millions (7 à 13 %) sont des cas sufﬁsamment graves 
pour imposer une hospitalisation. On ne dispose pas de données 
comparables pour le monde développé. Cependant, des études 
en populations de grande ampleur indiquent que l’incidence des 
pneumopathies contractées dans la communauté chez les enfants 
de moins de cinq ans est d’approximativement 0,026 ép/e.a, ce 
qui laisse à penser que plus de 95 % de l’ensemble des épisodes 
de pneumopathie clinique chez les jeunes enfants dans le monde 
surviennent dans les pays en développement.
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Resumen
Estimación mundial de la incidencia de neumonía clínica entre los menores de 5 años
Objetivo La neumonía clínica (deﬁnida como las infecciones 
respiratorias asociadas a signos clínicos de neumonía, principalmente 
neumonía y bronquiolitis) entre los menores de 5 años es todavía 
la principal causa de mortalidad en la niñez en el mundo. En este 
artículo hacemos una estimación de la incidencia mundial de 
neumonía clínica en los niños pequeños. 
Métodos Nuestras estimaciones para los países en desarrollo 
se han basado en un análisis de los datos publicados en estudios 
longitudinales comunitarios sobre la incidencia de neumonía clínica. 
Entre los más de 2000 estudios publicados desde 1961, identiﬁcamos 
46 en los que se notiﬁcaba la incidencia de neumonía clínica, 28 
de los cuales reunían los criterios de calidad preestablecidos.
Resultados La incidencia mediana estimada obtenida a partir 
de esos estudios fue de 0,28 episodios por niño y año (e/na). El 
intervalo intercuartílico 25%-75% fue de 0,21–0,71. Evaluamos 
la verosimilitud de esos valores empleando estimaciones de la 
mortalidad mundial por infecciones respiratorias agudas y las tasas 
de letalidad registradas para todos los episodios de neumonía 
clínica notiﬁcados en estudios comunitarios, o bien la tasa de 
letalidad notiﬁcada sólo para los casos graves y las estimaciones 
de la proporción de casos graves que ocurrían en una determinada 
población o comunidad.
Conclusión Considerando el solapamiento de los márgenes de 
las estimaciones, una estimación verosímil de la incidencia de 
neumonía clínica en los países en desarrollo es la cifra de 0,29 
e/na. Esto equivale a una incidencia anual de 150,7 millones de 
casos nuevos, de los cuales unos 11-20 millones (7%–13%) son 
suﬁcientemente graves para requerir hospitalización. En el mundo 
desarrollado no se dispone de datos comparables. Sin embargo, 
diversos estudios poblacionales muestran que la incidencia de 
neumonía adquirida en la comunidad entre los niños menores 
de cinco años es aproximadamente de 0,026 e/na, lo que lleva 
a pensar que más del 95% de todos los episodios de neumonía 
clínica que sufren los niños pequeños en todo el mundo se dan 
en los países en desarrollo.
903Bulletin of the World Health Organization | December 2004, 82 (12)
 Research 
Igor Rudan et al.  Estimate of global incidence of pneumonia among under-ﬁves 
 10.  James JW. Longitudinal study of the morbidity of diarrheal and respiratory  
  infections in malnourished children. American Journal of Clinical Nutrition  
  1972;25:690-4.
 11.  Borrero I, Fajardo L, Bedoya A, Zea A, Carmona F, de Borrero MF. Acute  
  respiratory infections among a birth cohort of children from Cali, Colombia,  
  who were studied through 17 months of age. Reviews of Infectious Diseases  
  1990;12 Suppl 8:S950-6.
 12.  Hortal M, Benitez A, Contera M, Etorena P, Montano A, Meny M. A  
  community-based study of acute respiratory tract infections in children in  
  Uruguay. Reviews of Infectious Diseases 1990;12 Suppl 8: S966-72.
 13.  Barreto ML, Santos LM, Assis AM, Araujo MP, Farenzena GG, Santos PA,  
  et al. Effect of vitamin A supplementation on diarrhoea and acute lower  
  respiratory tract infections in young children in Brazil. Lancet  
  1994;344:228-31.
 14.  Cruz JR, Pareja G, de Fernandez A, Peralta F, Caceres P, Cano F. Epidemiology 
  of acute respiratory infections among Guatemalan ambulatory pre-school  
  children. Reviews of Infectious Diseases 1990;12 Suppl 8: S1029-34.
 15.  Lanata CF: Incidence and evolution of pneumonia at the community level.  
  In: Benguigui Y, Antunano FL, Schmunis G, Yunes J, editors. In: Respiratory  
  infections in children: Integrated Management of Childhood Illness.  
  Washington (DC); Pan American Health Organization, World Health  
  Organization; 1999. p. 59-82. (Series HCT/AIEPI-1.I.)
 16.  Vathanophas K, Sangchai R, Raktham S, Pariyanonda A, Thangsuvan J,  
  Bunyaratabhandu P, et al. A community-based study of acute respiratory  
  tract infection in Thai children. Reviews of Infectious Diseases 1990;12  
  Suppl 8: S957-65.
 17.  Kartasasmita CB, Rosmayudi O, Deville W, Demedts M. Plasma retinol level,  
  vitamin A supplementation and acute respiratory infections in children  
  of 1-5 years old in a developing country. Tuberculosis and Lung Diseases  
  1995;76:563-9.
 18.  Dibley MJ, Sadjimin T, Kjolhede CL, Moulton LH. Vitamin A supplementation  
  fails to reduce incidence of acute respiratory illness and diarrhea in  
  preschool-age Indonesian children. Journal of Nutrition 1996;126:434-42.
 19.  Kamath KR, Feldman RA, Rao PS, Webb JK. Infection and disease in a group 
  of South Indian families. American Journal of Epidemiology 1969;8:375-83.
 20.  Black RE, Brown K, Becker S. Longitudinal studies of infectious diseases  
  and physical growth of children in rural Bangladesh. American Journal of  
  Epidemiology 1982;115:305-14.
 21.  Datta N, Kumar V, Kumar L, Singhi S. Application of case management to  
  the control of acute respiratory infections in low-birth-weight infants: A  
  feasibility study. Bulletin of the World Health Organization 1987;65:77-82.
 22.  Reddaiah VP, Kapoor SK. Acute respiratory infections in rural underﬁves.  
  Indian Journal of Pediatrics 1988;55:424-6.
 23.  Pandey MR, Sharma PR, Gubhaju BB, Shakya GM, Neupane RP, Gautam A,  
  et al. Impact of a pilot acute respiratory infection (ARI) control programme  
  in a rural community of the hill region of Nepal. Annals of Tropical Pediatrics 
  1989;9:212-20.
 24.  Pandey MR, Daulaire NM, Starbuck ES, Houston RM, McPherson K.  
  Reduction in total under-ﬁve mortality in western Nepal through community- 
  based antimicrobial treatment of pneumonia. Lancet 1991;338:993-7.
 25.  Singh MP, Nayar S. Magnitude of acute respiratory infections in under ﬁve  
  children. Journal of Communicable Diseases 1996;28:273-8.
 26.  Zaman K, Baqui AH, Yunus M, Sack RB, Bateman OM, Chowdhury HR, et al.  
  Acute respiratory infections in children: a community-based longitudinal  
  study in rural Bangladesh. Journal of Tropical Pediatrics 1997;43:133-7.
 27.  Riley I, Carad E, Gratten H. The status of research in acute respiratory  
  infections in children in Papua New Guinea. Pediatric Research  
  1983;17:1041-3.
 28.  Zhang ZJ, Gao LM, Wang ZL, Cao YP, Wu GC, Zhu ZH. Acute respiratory  
  infections in Beijing children: epidemiological studies at Dongguan Brigade.  
  Chinese Medical Journal 1986;99:561-8.
 29.  Zeng DL, Zhang ZJ, Wang ZL, Zhang JN, Yang ML. Surveillance of acute  
  respiratory infections in three kindergartens in Beijing. Chinese Medical  
  Journal 1988;101:787-92.
 30.  Tupasi TE, de Leon LE, Lupisan S, Torres CU, Leonor ZA, Sunico ES, et al.  
  Patterns of acute respiratory tract infection in children: a longitudinal study  
  in a depressed community in Metro Manila. Reviews of Infectious Diseases  
  1990;12 Suppl 8:S940-9.
 31.  Lehmann D. Mortality and morbidity from acute lower respiratory tract  
  infections in Tari, Southern Highland Province 1977-1983. Papua New  
  Guinea Medical Journal 1991;34 Suppl 1:S174-84.
 32.  Lehmann D. Epidemiology of acute respiratory tract infections, especially  
  those due to Haemophilus inﬂuenzae, in Papua New Guinean children.  
  Journal of Infectious Diseases 1992;165 Suppl 1:S20-5.
 33.  Hortal M, Contera M, Mogdasy C, Russi JC. Acute respiratory infections in  
  children from a deprived urban population from Uruguay. Revista do  
  Instituto de Medicina Tropical de Sao Paulo 1994;36:51-7.
 34.  Gordon JE, Ascoli W, Mata LJ, Guzman MA, Scrimshaw NS. Nutrition and  
  infection ﬁeld study in Guatemalan villages, 1959-1964. VI. Acute diarrheal  
  disease and nutritional disorders in general disease incidence. Archives of  
  Environmental Health 1968;16:424-37.
 35.  Phillips PA, Lehmann D, Spooner V, Barker J, Tulloch S, Sungu M, et al.  
  Viruses associated with acute lower respiratory tract infections in children  
  from the eastern highlands of Papua New Guinea (1983-1985). Southeast  
  Asian Journal of Tropical Medicine and Public Health 1990;21:373-82.
 36.  Qazi SA, Rehman GN, Khan MA. Standard management of acute respiratory 
  infections in a children’s hospital in Pakistan: impact on antibiotic use and  
  case fatality. Bulletin of the World Health Organization 1996;74:501-7.
 37.  Johnson AW, Osinusi K, Aderele WI, Adeyemi-Doro FA. Bacterial aetiology  
  of acute lower respiratory infections in pre-school Nigerian children and  
  comparative predictive features of bacteraemic and non-bacteraemic  
  illnesses. Journal of Tropical Pediatrics 1993;39:97-106.
 38.  Nathoo KJ, Nkrumah FK, Ndlovu D, Nhembe M, Pirie DJ, Kowo H. Acute  
  lower respiratory tract infection in hospitalized children in Zimbabwe.  
  Annals of Tropical Paediatrics 1993;13:253-61.
 39.  Banajeh SM, al-Sunbali NN, al-Sanahani SH. Clinical characteristics and  
  outcome of children aged under 5 years hospitalized with severe pneumonia  
  in Yemen. Annals of Tropical Paediatrics 1997;17:321-6.
 40.  Fagbule D, Adedoyin MA, Nzeh DA. Childhood pneumonia in the University  
  of Ilorin teaching hospital. Nigerian Journal of Paediatrics 1987;14:73-8.
 41.  Ruutu P, Halonen P, Meurman O, Torres C, Paladin F, Yamaoka K, et al.  
  Viral lower respiratory tract infections in Filipino children. Journal of  
  Infectious Diseases 1990;161:175-9.
 42.  Shann F, Gratten M, Germer S, Linnemann V, Hazlett D, Payne R. Aetiology  
  of pneumonia in children in Goroka Hospital, Papua New Guinea. Lancet  
  1984;2:537-41.
 43.  Bahl R, Mishra S, Sharma D, Singhal A, Kumari S. A bacteriological study  
  in hospitalized children with pneumonia. Annals of Tropical Paediatrics  
  1995;15:173-7.
 44.  Roy P, Sen PK, Das KB, Chakraborty AK. Acute respiratory infections in  
  children admitted in a hospital of Calcutta. Indian Journal of Public Health  
  1991;35:67-70.
 45.  Tupasi TE, Lucero MG, Magdangal DM, Mangubat NV, Sunico ME, Torres CU,  
  et al. Etiology of acute lower respiratory tract infection in children from  
  Alabang, Metro Manila. Rewiews of Infectious Diseases 1990;12 Suppl 8: 
  S929-39. 
 46.  Bashour HN, Webber RH, Marshall TF. A community-based study of acute  
  respiratory infections among preschool children in Syria. Journal of Tropical  
  Pediatrics 1994;40:207-13.
 47.  Chhabra P, Garg S, Mittal SK, Satyanarayan L, Mehra M, Sharma N.  
  Magnitude of acute respiratory infections in under ﬁve. Indian Pediatrics  
  1993;30:1315-9.
 48.  World Health Organization. Case management of acute respiratory  
  infections in children in developing countries. Report of a working group  
  meeting. Geneva: WHO; 1984. WHO document WHO/RSD/85.15, Rev.2.
 49.  Mulholland EK, Simoes EA, Costales MO, McGrath EJ, Manalac EM, Gove S.  
  Standardized diagnosis of pneumonia in developing countries. Pediatric  
  Infectious Disease Journal 1992;11:77-81.
 50.  Lanata CF, Quintanilla N, Verastegui HA. Validity of a respiratory  
  questionnaire to identify pneumonia in children in Lima, Peru. International  
  Journal of Epidemiology 1994;23:827-34.
 51.  McConnochie KM, Hall CS, Barher WH. Lower respiratory tract illness in the  
  ﬁrst two years of life: epidemiological patterns and costs in a suburban  
  pediatric practice. American Journal of Public Health 1988;78:34-9.
 52.  Foy HM, Cooney MK, Allan I, Kenny GE. Rates of pneumonia during  
  inﬂuenza epidemics in Seattle, 1964–1975. JAMA 1979;139:681-7.
ABulletin of the World Health Organization | December 2004, 82 (12)
 Research 
Igor Rudan et al.  Estimate of global incidence of pneumonia among under-ﬁves 
Table 1. Summary of 28 studies that satisﬁed inclusion criteria and were used to estimate the incidence of clinical pneumonia
Study Authors Year Country Setting Ma- Popu- Altitude/ Study Cohort Surveil- Person Case Site of Incidence 
no.a and  pub-   laria lation rainfall/ period  lance making deﬁni- diag- of acute 
 refer- lished   risk type temp.   intervals diag- tion nosis lower  
 ence no.          nosisb cate-  respiratory 
            goryc  infectionsd
African Region, subregion D
1 Campbell  1989 Gambia Basse High Rural 10m/ 12 491 Weekly TFW I B, W–, Home Age 0–4 
 et al. (5)      975mm/ months children  (and phy- C/R– and years: 
       27 ºC (03/87– aged 0–4  sician)  hospital  0.45/cy; 
        03/88) years      Age 0–4XR 
              years:  
              0.16/cy
2 Oyejide &  1990 Nigeria Ibadan High Urban 200m/ 36 400 Weekly FW I C, W–,  Clinic Age 0–4 
 Osinusi      1637mm/ months children  (and phy- C/R+ and years:  
 (6)      28 ºC (10/84– aged 0–4  sician)  home 0.22/cy; 
        10/87) years     Age 0–4MI 
               years: 
              0.08/cy
3 Afari  1991 Ghana Central High Rural 300m/ 36 440 Weekly Nurses I B, W–, Clinic Age 0–4 
 et al. (7)   Ghana   1100mm/ months children  (and phy- C/R– and years: 
       27 ºC  (01/87– aged   sician)  home 0.06/cy 
        12/89) 0–4 
         years
4 Fagbule  1994 Nigeria Ilorin, High Suburban 150m/ 12 481 3x / TFW I A, W+, Home Age 0–4 
 et al. (8)    Kwara    1100mm/ months children week  C/R–  years: 
    state   28 ºC (07/88– aged 0–4     1.30/cy 
        06/89) years
African Region, subregion E
5 Wafula  1990 Kenya Maragua None Rural 1650m/ 36 470 Weekly FW I C, W–, Clinic Age 0–4 
 et al. (9)      1200mm/ months children  (and phy-  C/R+ and years: 
       18 ºC (02/85– aged 0–4  sician)  home 0.21/cy 
        01/88) years
Region of the Americas, subregion  B
6 James 1972 Costa Rica San Jose Low Suburban 1170m/  12 137 Weekly Physician II Home Age 0–4 
 (10)      2500mm/ months children     years: 
       21 ºC (03/66– aged 0–4     0.04/cy 
        04/67)  years     Age 0–4MN  
              years: 
              0.46/cy
7 Borrero  1990 Colombia Cali Low Urban 1100m/ 36 340 Weekly TFW I C, W–, Clinic Age 0–1.5 
 et al. (11)      1000mm/ months children    C/R+  years: 
       25 ºC (01/87– aged     1.71/cy; 
        12/89) 0–1.5     Age 0–4IA 
         years     years: 
              1.02/cy
8 Hortal  1990 Uruguay Monte- None Urban 22m/ 32 166 10 days Paediatrician II Home Age 0–2 
 et al. (12)   video   1075mm/ months children     years: 
       16 ºC (05/85– aged 0–2     1.80/cy; 
        12/87) years     Age 0–4IA 
              years:  
              1.17/cy
9 Barreto  1994 Brazil Serrinha, None Urban 90m/ 12 1 240 Fort- Paediatrician II Home Age  
 et al. (13)    Bahia   1346mm/ months children nightly (with FW)  and 0.5–3VA 
    state   23 ºC (12/90– aged     hospital years: 
        12/91) 0.5–3     0.26/cy; 
         years      Age 0–4IA 
              years: 
              0.21/cy
Region of the Americas, subregion D
10 Cruz et al.  1990 Guate- Guatemala None Suburban 1480m/ 24 521 Fort- TFW (and I C, W–, Clinic Age 0–4 
 (14)  mala City   1346mm/ months children nightly  physician) C/R+  years: 
       21 oC (01/85– aged 0–4     0.31/cy 
        12/86) years 
11 Lanata  1994 Peru Canto None Suburban 154m/ 27 1500 2x /  Physician II Home Age 0–3XR 
 et al. (15)   Grande,   0 mm/ months children week (and TFW)  and years: 
    Lima   22 ºC (07/87– aged    clinic 0.08/cy 
        10/89) 0–2.5     Age 0–4IA 
         years     years: 
              0.25/cy
South-East Asia Region, subregion B
12 Vathanophas 1990 Thailand Bangkok Low Urban 2m/ 24 674 2x / TFW (and I C, W–, Home Age 0–4 
 et al. (16)      400mm/ months children week physician) C/R+  years: 
       29 ºC (01/86– aged 0–4      0.07/cy 
        12/87) years
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(Table 1, cont.)
Study Authors Year Country Setting Ma- Popu- Altitude/ Study Cohort Surveil- Person Case Site of Incidence 
no.a and  pub-   laria lation rainfall/ period  lance making deﬁni- diag- of acute 
 refer- lished   risk type temp.   intervals diag- tion nosis lower  
 ence no.          nosisb cate-  respiratory 
            goryc  infectionsd
13 Kartasasmita  1995 Indonesia Cikutra, Low Suburban 770m/ 12 269 Fort- PHCW I C, W–, Home Age 1–3.5 
 et al. (17)   Bandung   2000mm/ months children nightly paediatri- C/R+   years: 
       27 ºC (06/89– aged  cian)   2.00/cy; 
        05/90) 1–3.5     Age 0–4IA 
         years     years: 
              2.45/cy
14 Dibley  1996 Indonesia Southern None Rural 1500m/ 20 1407 3x /  TFW I A, W+, Home Age 0.5–4 
 et al. (18)   Central   1000mm/ months children week  C/R–  years: 
    Java   24 ºC (09/89– aged      0.10/cy; 
        05/91) 0.5–4     Age 0–4IA 
         years     years: 
              0.11/cy
South-East Asia Region, subregion D
15 Kamath  1969 India Vellore Low Suburban 204m/ 21 122 2x / Physician II Home Age 0–4 
 et al. (19)      1053mm/ months children week (and nurse)   years: 
       28 ºC (06/65– aged 0–4     0.22/cy 
        09/67) years        
16 Black  1982 Bangla- Matlab High Rural 0m/ 12 197 3x / Physician II Home Age 0–4 
 et al. (20)  desh    1500 mm/ months children week (and FW)   years: 
       25 ºC (03/78– aged 0–4     1.10/cy 
        03/79) years
17 Datta  1987 India Haryana, Low Rural 274m/ 21 347 Weekly TFW I B, W+, Home Age 0–1MN 
 et al. (21)   Ambala   1100mm/ months children   C/R–  years: 
       23 ºC (01/82– aged 0–1     0.35/cy; 
        09/83) years     Age 0–4IA 
              years: 
              0.18/cy
18 Reddaiah & 1988 India Haryana Low Rural 274m/ 12 5 078 Fort- TFW I B, W–, Home Age 0–4 
 Kapoor (22)      1100mm/ months children nightly  C/R+  years: 
       23 ºC (01/86– aged     0.54/cy 
        12/86) 0–4 
         years
19 Pandey  1989 Nepal Kathmandu None Rural 2000m/ 36 1 019 Fort- TFW I B, W+, Home Age 0–4 
 et al. (23)      1300mm/ months children nightly  C/R+  years: 
       20 ºC (02/84– aged     0.25/cy 
        01/87) 0–4 
         years
20 Pandey  1991 Nepal Yumla None Rural 2500m/ 36 13 404 Fort- TFW I A, W+, Home Age 0–4 
 et al. (24)       1300mm/ months children nightly  C/R–  years: 
       20 ºC (06/86– aged 0–4     0.75/cy 
        06/89) years
21 Singh and  1996 India Wardha Low Rural 234m/ 12 384 Fort- Not I A, W+, Home Age 0–4 
 Nayar (25)   district,   600mm/ months children nightly reported C/R–  years: 
    Maharastra   27 ºC (09/90– aged 0–4  (probably   0.07/cy 
        08/91) years  TFW)
22 Zaman 1997 Bangla- Matlab High Rural 0m/ 12 696 2 times/ TFW I B, W–, Home Age 0–4 
 (26)  desh    1500mm/ months children week  C/R–  years: 
       25 ºC (05/88– aged     0.23/cy 
        04/89) 0–4 
         years
Western Paciﬁc Region, subregion B
23 Riley  1983 Papua Tari and  None Rural 1700m/  12 & 48 1 595 Fort- TFW (and I B, W–,  Home Age 0–4 
 et al. (27)  New Asaro   4000mm/ months and nightly physician) C/R– and years: 
   Guinea    18 ºC (72–73,  1 000    hospital 0.67/cy 
        79–83) children  
         aged 0–4 
         years
24 Zhang  1986 China Changping None Semirural 17m/  24 526 Weekly Physician II Home, Age 0–4 
 et al. (28)    County   630mm/ months children    primary years: 
       15 ºC (06/81– aged    school 0.33/cy 
        06/83)  0–11 
         years
25 Zeng  1988 China Not Various Various Various 12 1 312 Daily Physician II Nursery Age 0.5–6 
 et al. (29)    applicable    months children     years: 
    (various)    (01/85– aged      0.30/cy; 
        12/85) 0.5–6     Age 0–4IA 
         years     years: 
              0.37/cy
26 Tupasi  1990 Philippines Albang, Low Urban 14m/ 24 1 978 Weekly Nurse I C, W–, Home Age 0–4 
 et al. (30)    Manila    2082mm/ months children  (and phy- C/R+ and years: 
       27 ºC (04/85– aged 0–4  sician)  clinic 0.57/cy 
        03/87) years
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Study Authors Year Country Setting Ma- Popu- Altitude/ Study Cohort Surveil- Person Case Site of Incidence 
no.a and  pub-   laria lation rainfall/ period  lance making deﬁni- diag- of acute 
 refer- lished   risk type temp.   intervals diag- tion nosis lower  
 ence no.          nosisb cate-  respiratory 
            goryc  infectionsd
27 Lehmann  1991 Papua Tari None Rural 1700m/ 25 2 000 Fort- Lay I B, W+, Home Age 0–4 
 et al. (31)  New  Basin   2000mm/ months children nightly reporters C/R– and  years: 
   Guinea    18 ºC (10/81– aged 0–9    hospital 0.20/cy; 
        11/83) years     Age 0–4PV 
              years: 
              0.15/cy
28 Lehmann 1992 Papua Asaro None Rural 1700m/ 36 156 2  Lay I B, W+, Home Age 0–4 
 et al. (32)  New Valley   2000mm/ months children times/ reporters C/R–  years: 
   Guinea    18 ºC (01/85– aged 0–4 week    1.30/cy 
        12/87) years
a  To ﬁnd out more about WHO regions and subregions see http://www.who.int. 
b  For the person diagnosing clinical pneumonia, the following abbreviations are used: TFW = Trained ﬁeld worker; FW = Field worker with no training;  
 PHCW = primary health care worker.
c  For the case deﬁnition category, the following abbreviations are used: I A–C = WHO deﬁnitions; II = Physician’s assessment; W+ = Wheeze part of case deﬁnition;  
 W– = Wheeze not part of case deﬁnition; C+/R+ = Crepitations/rales part of deﬁnition of acute lower respiratory infection; C– /R– = Crepitations/rales not part  
 of deﬁnition of acute lower respiratory infection;  XR = X-ray conﬁrmed; MI = Measles immunized; MN = Malnourished; IA = Incidence adjusted to full 0–4 year  
 age range; VA = Vitamin A supplementation administered; PV = Pneumococcal vaccine administered.
d  Incidence expressed as episodes/child-year (e/cy).
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Table 2. Correlation coefﬁcients between 15 variables from 28 selected studies and incidence of clinical pneumonia
Variable Description Correlation Correlation  Standardized  P-value 
no. of variable coefﬁcient coefﬁcient > 0.50 multiple regression 
   between variables coefﬁcient (β)
1 Calendar year of study  0.165 -0.52  (variable 11) 0.529 0.069 
 (median if longer than 1 year)
2 Population type (categorized as  0.116 -0.54  (variable 12); 0.201 0.309 
 rural, suburban or urban)  -0.51  (variable 14) 
3 Altitude (m) 0.048 -0.51  (variable 5); NA  NA 
   -0.55  (variable 6)
4 Annual rainfall (mm) 0.240     NAa 0.607 0.026
5 Average annual temperature (ºC) 0.010 -0.51  (variable 3); NA  NA  
   0.79  (variable 6)
6 Risk of malaria (categorized  0.048 -0.55  (variable 3); NA  NA 
 as none, low or high)  0.79  (variable 5)  
7 Duration of follow-up (months) -0.087     NA  -0.040 0.844
8 Cohort size  0.019     NA  NA  NA 
9 Surveillance intervals (days) 0.066     NA  NA  NA 
10 Person making diagnosis  -0.083 0.54  (variable 12); NA  NA 
   0.64  (variable 13)
11 Case deﬁnition variable 1  -0.168 -0.52  (variable 1); 0.164 0.548 
 (non-physician applying WHO deﬁnition   0.76  (variable 12); 
 vs physician using auscultation)      0.80  (variable 13); 
   0. 82  (variable 14) 
12 Case deﬁnition variable 2 (same -0.026 0.54  (variable 2); NA  NA 
 (same as variable 11 above, but corrected   0.54  (variable 10); 
 for additional diagnostic criteria used)  0.76  (variable 11); 
   0.90  (variable 13); 
   0.92  (variable 14) 
13 Case deﬁnition variable 3  -0.091 0.64  (variable 10); NA  NA 
 (same as variable 11 above, but corrected    0.80  (variable 11); 
 for inclusion of wheeze in deﬁnition)  0.90  (variable 12); 
   0. 85  (variable 14)  
14 Case deﬁnition variable 4 (same -0.046 0.51  (variable 2); NA  NA 
 as variable 11 above, but corrected for  0.82  (variable 11); 
 inclusion of crepitations/rales in deﬁnition)  0.92  (variable 12); 
   0.85  (variable 13)  
15 Place of diagnosis (categorized -0.226     NA  -0.465 0.035  
 as home, clinic or hospital)
Summary of multiple  R = 0.581;  R2 = 0.338;  Adjusted R2 = 0.139;  SE = 0.513;  F ratio = 1.698;  P = 0.173 
regression analysisa
a  NA = not applicable.
b  R = multiple regression for the model; R2 = non-adjusted proportion of variance explained; Adjusted R2 = adjusted proportion of variance explained;  
 SE = standard error of the estimate; F ratio = analysis of variance.
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Appendix 1. Case deﬁnition variablesa
Assigned Case deﬁnition Case deﬁnition Case deﬁnition Case deﬁnition 
value variable 1b variable 2 variable 3 variable 4
1 The majority (or all) cases  Deﬁnition as for CDV1  Deﬁnition as for CDV1 Deﬁnition as for CDV1 
 of clinical pneumonia in a with an assigned value with an assigned value with assigned value of 1 
 community were diagnosed  of 1 plus WHO deﬁnition of 1 but WHO deﬁnition but WHO deﬁnition (with 
 by a non-physician using  applied without any (with or without additional or without additional 
 WHO deﬁnitionsc  additional diagnostic  diagnostic criteria) diagnostic criteria) did not 
  criteria included wheeze  include crepitations or rales 
2 The majority of cases of  Deﬁnition as for CDV1 Deﬁnition as for CDV1 Deﬁnition as for CDV1 
 clinical pneumonia in a  with assigned value with assigned value with assigned value of 1 
 community were diagnosed  of 1 plus WHO deﬁnition of 1 but WHO deﬁnition but WHO deﬁnition (with 
 by physicians or paediatricians  applied with 1–3 additional (with or without additional or without additional 
 using their own clinical  diagnostic criteria (such diagnostic criteria) did diagnostic criteria) also 
 assessment (relying on  as cyanosis, shock, heart not include wheeze included crepitations or rales 
 auscultation)d failure)
        
3 NAe Deﬁnition as for CDV1  The majority of cases of The majority of cases of 
  with assigned value  clinical pneumonia clinical pneumonia in a 
  of 1 and WHO deﬁnition  in a community were community were diagnosed 
  applied with four or more  diagnosed by physicians by physicians or 
  additional diagnostic  or paediatricians based paediatricians based on 
  criteria (such as cyanosis,  on their own clinical their own clinical 
  shock, heart failure)  assessment (relying on  assessment (relying on 
   auscultation)  auscultation)
 
4 NA The majority of cases of  NA NA 
  clinical pneumonia   
  in a community were  
  diagnosed by physicians  
  or paediatricians based  
  on their own clinical  
  assessment (relying on  
  auscultation)
a  For all case deﬁnitions the variables move from looser deﬁnitions to stricter deﬁnitions so that a negative correlation with the estimates of incidence is expected.
b  CDV1 = Case deﬁnition variable 1; CDV2 = Case deﬁnition variable 2; CDV3 = Case deﬁnition variable 3; CDV4 = Case deﬁnition variable 4.
c  Due to the variability in approaches found for this assigned value, case deﬁnition variables 2–4 are further deﬁned and categorized in an attempt to achieve a  
 greater correlation coefﬁcient with the resulting incidence.
d  There was less variability in approaches for this assigned value. It was expected to give lower estimates than any further subcategory of case deﬁnition variable 1,  
 assigned value 1. Therefore, for case deﬁnition variables 2–4 , this assigned value (case deﬁnition variable 1, assigned value 2) remains unchanged. 
e  NA = not applicable.
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